Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Norvaline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 4/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.47 |
| ▸ | NOS1 | P29475 | 4/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norvaline SCHEMBL2517585 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL2517586 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL2512779 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL2513626 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL2513624 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL2512780 | 0.94 | SLC1A2 (0.52) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL167818 | 0.93 | SLC1A2 (0.49) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Cadaverine Tartrate SCHEMBL1685899 | 0.87 | SLC1A2 (0.44) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL166373 | 0.85 | SLC1A2 (0.41) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 | |
| Norvaline SCHEMBL167816 | 0.82 | NOS1 (0.42) | SLC1A2SLC1A1GRIK1GRIK2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170105959-A1 | COMPOSITIONS CONTAINING NITRIC OXIDE AMINO ACID ESTERS AND METHODS FOR IMPROVING SEXUAL PERFORMANCE | SMARTEK INTERNATIONAL, INC. | 2017-04-20 | — | — | US | disclosed |
| WO-2012027827-A1 | NITRIC OXIDE AMINO ACID ESTERS FOR SKIN REJUVENATION | ORAL DELIVERY TECHNOLOGY LTD. (CA) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170105959-A1 | COMPOSITIONS CONTAINING NITRIC OXIDE AMINO ACID ESTERS AND METHODS FOR IMPROVING SEXUAL PERFORMANCE | NOS1, NOS2, NOS3 | SLC1A2 80/4885SLC1A1 99/4885GRIK1 2488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.